These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1971589)
21. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes. Watanabe K; Hirokawa Y; Shibata A J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309 [TBL] [Abstract][Full Text] [Related]
22. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris. Barrios L; Geboers J; Piessens JH; de Geest H Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055 [TBL] [Abstract][Full Text] [Related]
23. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol. Mehlsen J; Trap-Jensen J Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593 [TBL] [Abstract][Full Text] [Related]
24. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure. Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946 [TBL] [Abstract][Full Text] [Related]
25. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle. Vigholt-Sørensen E; Faergeman O; Snow HM Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049 [TBL] [Abstract][Full Text] [Related]
26. Modulation of the autonomic control of the failing heart. Snow HM Basic Res Cardiol; 1989; 84 Suppl 1():163-76. PubMed ID: 2573339 [TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine changes post myocardial infarction: effects of xamoterol. McMurray JJ; Lang CC; MacLean D; McDevitt DG; Struthers AD Am Heart J; 1990 Jul; 120(1):56-62. PubMed ID: 1972861 [TBL] [Abstract][Full Text] [Related]
28. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction. Pouleur H; Hanet C; Rousseau MF Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587 [TBL] [Abstract][Full Text] [Related]
29. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)]. Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823 [TBL] [Abstract][Full Text] [Related]
30. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure. Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation. Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836 [TBL] [Abstract][Full Text] [Related]
32. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial. de Feyter PJ; Serruys PW; Suryapranata H Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562 [TBL] [Abstract][Full Text] [Related]
33. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction. Molajo AO; Bennett DH Br Heart J; 1985 Jul; 54(1):17-21. PubMed ID: 2861834 [TBL] [Abstract][Full Text] [Related]
34. Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial. de Feyter PJ; Serruys PW Eur Heart J; 1990 Apr; 11 Suppl A():48-9. PubMed ID: 1971590 [TBL] [Abstract][Full Text] [Related]
35. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course. McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047 [TBL] [Abstract][Full Text] [Related]
36. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure]. Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820 [No Abstract] [Full Text] [Related]